| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TSLA | Consumer Cyclical | China Renaissance | Maintains | Buy → Buy | — | $1.4T | $15.25 | +0.9% | +6.0% | -0.2% | -0.5% | +1.6% | -0.6% |
| ABBV | Healthcare | CitigroupC | Upgrade | Neutral → Buy | — | $376.6B | $72.09 | +1.2% | +2.7% | +1.1% | +1.2% | -3.3% | -1.5% |
| UNH | Healthcare | Morgan Stanley | Maintains | Overweight → Overweight | — | $354.2B | $222.17 | +0.4% | -3.0% | -0.1% | +1.0% | -0.1% | -0.2% |
| CRWD | Technology | Baird | Maintains | Neutral → Neutral | — | $159.2B | $62.02 | +0.0% | -6.0% | -8.3% | +9.1% | -0.7% | -2.2% |
| CVS | Healthcare | Morgan Stanley | Maintains | Overweight → Overweight | — | $119.7B | $62.59 | +0.1% | -1.6% | +0.8% | +1.6% | -1.1% | -1.4% |
| ELV | Healthcare | Morgan Stanley | Maintains | Overweight → Overweight | — | $89.2B | $244.00 | -0.1% | -2.1% | -0.5% | +1.0% | -0.7% | -0.2% |
| CI | Healthcare | Morgan Stanley | Maintains | Overweight → Overweight | — | $77.5B | $155.22 | +0.4% | -3.5% | -0.2% | +1.5% | -0.9% | -0.8% |
| IMO | Energy | Goldman Sachs | Downgrade | Buy → Neutral | — | $69.4B | $26.69 | -6.2% | -1.3% | -0.0% | -1.1% | -1.4% | -2.4% |
| NKE | Consumer Cyclical | Argus | Maintains | Buy → Buy | — | $63.1B | $90.81 | +0.9% | +1.5% | +0.2% | +1.7% | -1.7% | -0.9% |
| NKE | Consumer Cyclical | Citigroup | Maintains | Buy → Buy | — | $63.1B | $90.81 | +0.9% | +1.5% | +0.2% | +1.7% | -1.7% | -0.9% |
| CVE | Energy | Goldman SachsB | Upgrade | Neutral → Buy | — | $57.9B | $9.72 | +0.1% | -0.4% | -0.7% | -2.4% | -2.8% | -4.4% |
| WPM | Basic Materials | BofA Securities | Maintains | Buy → Buy | — | $56.4B | $27.43 | +0.4% | +0.2% | -2.7% | -1.9% | +1.0% | +1.9% |
| CUK | Consumer Cyclical | Nomura | Maintains | Neutral → Neutral | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| CUK | Consumer Cyclical | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| CUK | Consumer Cyclical | Berenberg | Downgrade | Hold → Sell | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| CUK | Consumer Cyclical | Wedbush | Maintains | Neutral → Neutral | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| CUK | Consumer Cyclical | UBS | Downgrade | Buy → Neutral | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| CUK | Consumer Cyclical | Stifel | Maintains | Buy → Buy | — | $38.5B | $46.42 | -6.1% | -8.7% | -0.9% | +0.3% | -3.2% | -2.5% |
| HUM | Healthcare | Morgan Stanley | Maintains | Overweight → Overweight | — | $37.5B | $267.69 | +0.2% | -1.4% | -2.4% | -0.7% | -0.5% | +0.4% |
| NTRS | Financial Services | UBS | Downgrade | Buy → Neutral | — | $31.1B | $95.31 | -1.0% | -1.4% | -0.8% | +0.2% | -3.7% | -3.0% |